We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Multiple patent infringement lawsuits filed in federal court by Teva Pharmaceutical against competitors gearing up to market their own generic versions of Zoloft could jeopardize their efforts, legal sources say.
An HIV/AIDS healthcare provider has filed a lawsuit against Pfizer, saying its marketing campaign for Viagra promoted recreational use of the drug and contributed to increased incidence of sexually transmitted diseases (STDs), including HIV.
The U.S. Court of Appeals for the Federal Circuit brushed off an eleventh-hour request by Apotex asking it to reverse a decision it made last month upholding a block on sales of generic Plavix.
A federal court has upheld a preliminary injunction preventing Watson subsidiary Andrx Pharmaceuticals from marketing clarithromycin, a generic version of Abbott Laboratories’ extended-release antibiotic Biaxin XL.
A federal court invalidated one of two patents challenged by Sun Pharmaceuticals to market amifostine, a generic version of MedImmune Oncology’s dry mouth treatment drug, Ethyol.
A company’s right to challenge a patent that it is licensed to use is not restricted by the licensing agreement between it and the patent holder, the U.S. Supreme Court said in a Jan. 9 ruling.
The U.S. Court of Appeals for the Federal Circuit brushed off an eleventh-hour request by Apotex asking it to reverse a decision it made last month upholding a block on sales of generic Plavix.
A jury has failed to return verdicts in two Vioxx liability suits against Merck filed by former patients who claimed that the drug contributed to their heart attacks.
A federal district court has ordered Abbott Laboratories to immediately stop selling its diagnostic testing products developed with patented hepatitis C virus technology owned by biotech firm Innogenetics.
A federal court last week upheld one of two patents challenged by Sun Pharmaceutical Industries to market amifostine, a generic version of MedImmune Oncology’s dry mouth treatment drug, Ethyol.